Cargando…
Recent Advances in the Treatment of Neurodegenerative Disorders
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
UAE :
Bentham Science Publishers,
2021.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover
- Title
- Copyright
- End User License Agreement
- Contents
- Foreword
- Preface
- Acknowledgements
- List of Contributors
- An Introduction to Neurodegenerative Diseases and its Treatment
- Payal Singh1 and Sachchida Nand Rai2,*
- INTRODUCTION
- AYURVEDA IN NEURODEGENERATIVE DISEASES (NDS)
- VITAMINS IN NEURODEGENERATIVE DISEASES (NDS)
- GUT-BRAIN AXIS AND ASSOCIATED PRO AND PRE-BIOTICS THERAPY FOR NDS
- NANOPARTICLES AND NANOFORMULATION BASED THERAPY FOR DIFFERENT NDS
- CONCLUSION
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- REFERENCES
- Recent Advancement in the Treatment of Neurodegenerative Diseases by Ayurveda
- Mridula Chaturvedi and Abhishek Kumar Chaturvedi*
- INTRODUCTION
- OVERVIEW OF NEURODEGENERATIVE DISEASES (NDDS)
- The Preamble of Common Neurodegenerative Diseases
- Alzheimer's Disease (AD)
- Parkinson's Disease (PD)
- Huntington's Disease (HD)
- Pathogenesis of Neurodegenerative Diseases
- Pathway of Development of Neurodegenerative Diseases
- Common Signs andamp
- Symptoms of Neurodegenerative Diseases
- Diagnosis of Neurodegenerative Diseases
- A RANGE OF TREATMENT FOR THE NEURODEGENERATIVE DISEASES
- The Modern System of Medicine
- Medical Management
- Surgical Management
- Emerging Management
- Ayush or Indian System of Medicine
- RECENT ADVANCEMENT IN THE AYURVEDIC MANAGEMENT OF NEURODEGENERATIVE DISEASES
- Ayurvedic/herbal Medicinal Plants
- Different Actions of an Extract Derived from Ayurvedic Medicinal Plants
- Herbo-mineral Drugs
- Panchkarma (Bio-purification Procedures)
- Overview of Panchkarma Therapy
- Studies Conducted in Different Panchkarma Procedures
- CONCLUDING REMARKS
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- REFERENCES
- Role of Phytochemicals in Neurodegenerative Disorders.
- Symptoms of PD
- Treatment Strategies for PD
- Dopamine Replacement Therapy (DRT)
- L-DOPA: Promising DRT for PD
- Anti-inflammatory Agents and Protein Anti-Aggregants
- ROLE OF GUT MICROBIOME IN METABOLISM AND HEALTH
- Role of Prebiotics in Gut Microflora Balance
- Gut Microbiome and Neurodegenerative Disease
- Gut and Alzheimer's Disease
- Therapeutic Role of Probiotics in AD
- Prebiotics For AD
- Gut Microbiome and Parkinson's Disease
- Probiotics and Prebiotics for PD
- Mediterranean Diet
- Ketogenic Diet and Fasting
- Polyphenols
- CONCLUDING REMARKS
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- REFERENCES
- Therapeutic Efficacy of Mushroom in Neurodegenerative Diseases
- Ankita Kushwaha1,*, Vivek K. Chaturvedi2, Sachchida Nand Rai2, Sanjay C. Masih3 and M. P. Singh2
- INTRODUCTION
- NEUROPROTECTIVE EFFECTS OF MUSHROOMS AGAINST NEURODEGENERATIVE DISEASE
- ADVANTAGEOUS EFFECTS OF MUSHROOMS AGAINST NDS
- Role of Mushrooms in Alzheimer's Disease (AD)
- Mushrooms Having Beneficial Effects Against Parkinson's Pisease (PD)
- CONCLUSIONS
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- REFERENCES
- Advances in Experimental Animal Models Provide Insights into Different Etiology and Mechanism of Multiple Sclerosis to Design Therapeutics
- Sourodip Sengupta and Jayasri Das Sarma*
- INTRODUCTION
- CLASSIFICATION OF MS
- ETIOLOGY OF MS
- CLINICAL SYMPTOMS AND DIAGNOSIS
- PRESENT THERAPEUTICS AND LIMITATIONS
- EXPERIMENTAL ANIMAL MODELS TO UNDERSTAND THE MECHANISMS OF MS
- EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE)
- EXPERIMENTAL VIRAL-INDUCED MODEL OF MS
- TMEV MODEL
- MHV MODEL
- MHV MEDIATED IMMUNE RESPONSES
- Recombinant Demyelinating (DM) And Non-Demyelinating (NDM) Mhv Strains
- CONCLUDING REMARKS
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST.
- ACKNOWLEDGEMENTS
- REFERENCES
- Novel Therapeutic Targets in Amyotrophic Lateral Sclerosis
- Priyanka Gautam, Mukesh Kumar Jogi and Abhishek Pathak*
- INTRODUCTION
- HISTORY
- EPIDEMIOLOGY
- SIGN AND SYMPTOMS
- CLINICAL CHARACTERISTICS
- GENETICS
- MUTATION
- ALS PATHOGENIC PATHWAYS AS THERAPEUTIC TARGETS
- TARGETING OXIDATIVE STRESS
- TARGETING GLUTAMATE TRANSPORT
- TARGETING PROTEIN AGGREGATION
- TARGETING MITOCHONDRIAL DYSFUNCTION
- TARGETING APOPTOSIS
- TARGETING NEUROINFLAMMATION
- TARGETING GLIAL CELLS (MICROGLIA AND ASTROCYTES)
- TARGETING DYSREGULATED RNA PROCESS
- TARGETING NEUROMUSCULAR JUNCTION
- TARGETING GENE
- CONCLUDING REMARKS
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- REFERENCES
- Impact of Nano-Formulations of Natural Compounds in the Management of Neuro degenerative Diseases
- Hemraj Heer1, Vishav Prabhjot Kaur1, Tania Bajaj1, Arti Singh2, Priyanka Bajaj3 and Charan Singh1,*
- INTRODUCTION
- NEUROPROTECTIVE POTENTIAL OF NATURAL PRODUCTS
- APPROACHES FOR CNS TARGETED NATURAL COMPOUNDS DELIVERY
- NANO-BASED DELIVERY SYSTEMS FOR NEURODEGENERATIVE DISORDERS
- LIPIDIC NANOMATERIALS
- Liposomes
- Solid Lipid Nanoparticles and Nanostructured Lipid Carrier Systems
- Carbon Nanomaterials
- Carbon Nanotubes
- Nanodiamonds
- Polymeric Systems
- Dendrimers
- Metal-organic Frameworks (MOFs)
- Semiconducting Nanoparticles And Quantum Dots
- Phospholipid Complexes
- METHODS OF NANOFORMULATIONS PREPARATION
- Emulsion-solvent Evaporation Method
- Solvent Diffusion Method
- Salting Out Method
- Supercritical Fluid Technique
- Polymerization Technique
- NATURAL COMPOUNDS NANO-DELIVERY IN NEURO DEGENERATIVE DISEASES
- Alzheimer's Disease
- Huntington's Disease
- Parkinson's Disease
- CONCLUSION
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS.